Mascoma Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-5
| Closed | -$624 | – | 530 |
|
2024
Q3 | $624 | Hold |
5
| – | – | ﹤0.01% | 441 |
|
2024
Q2 | $790 | Hold |
5
| – | – | ﹤0.01% | 473 |
|
2024
Q1 | $647 | Hold |
5
| – | – | ﹤0.01% | 442 |
|
2023
Q4 | $482 | Hold |
5
| – | – | ﹤0.01% | 459 |
|
2023
Q3 | $606 | Hold |
5
| – | – | ﹤0.01% | 489 |
|
2023
Q2 | $516 | Hold |
5
| – | – | ﹤0.01% | 471 |
|
2023
Q1 | $614 | Hold |
5
| – | – | ﹤0.01% | 573 |
|
2022
Q4 | $648 | Hold |
5
| – | – | ﹤0.01% | 596 |
|
2022
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 588 |
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 639 |
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 607 |
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 563 |
|
2021
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 467 |
|
2021
Q2 | – | Sell |
-5
| Closed | – | – | 380 |
|
2021
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 464 |
|